AbbVie Inc Acquisition of Immunogen in the News
AbbVie Inc. (ABBV) and ImmunoGen (IMGN) today announced a definitive agreement under which AbbVie will acquire . . .
This content is for paid subscribers.
Today’s Highlights
November 30, 2023
